166 related articles for article (PubMed ID: 2318536)
1. Differences in susceptibilities of the lymphogranuloma venereum and trachoma biovars of Chlamydia trachomatis to neutralization by immune sera.
Peterson EM; Hoshiko M; Markoff BA; Lauermann MW; de la Maza LM
Infect Immun; 1990 Apr; 58(4):938-43. PubMed ID: 2318536
[TBL] [Abstract][Full Text] [Related]
2. Systemic Chlamydia trachomatis infection in mice: a comparison of lymphogranuloma venereum and trachoma biovars.
Brunham RC; Kuo C; Chen WJ
Infect Immun; 1985 Apr; 48(1):78-82. PubMed ID: 3980097
[TBL] [Abstract][Full Text] [Related]
3. Trachoma and LGV biovars of Chlamydia trachomatis share the same glycosaminoglycan-dependent mechanism for infection of eukaryotic cells.
Chen JC; Stephens RS
Mol Microbiol; 1994 Feb; 11(3):501-7. PubMed ID: 8152374
[TBL] [Abstract][Full Text] [Related]
4. Sequence diversity of the 60-kilodalton protein and of a putative 15-kilodalton protein between the trachoma and lymphogranuloma venereum biovars of Chlamydia trachomatis.
de la Maza LM; Fielder TJ; Carlson EJ; Markoff BA; Peterson EM
Infect Immun; 1991 Mar; 59(3):1196-201. PubMed ID: 1997423
[TBL] [Abstract][Full Text] [Related]
5. Plasmid Negative Regulation of CPAF Expression Is Pgp4 Independent and Restricted to Invasive
Patton MJ; Chen CY; Yang C; McCorrister S; Grant C; Westmacott G; Yuan XY; Ochoa E; Fariss R; Whitmire WM; Carlson JH; Caldwell HD; McClarty G
mBio; 2018 Jan; 9(1):. PubMed ID: 29382731
[No Abstract] [Full Text] [Related]
6. Monoclonal antibody neutralization of unmanipulated Chlamydia trachomatis serovar A infection of human epithelioid cells (A-431).
Barsoum IS; Goodman TA; Hardin LK; Colley DG
Med Microbiol Immunol; 1989; 178(2):113-20. PubMed ID: 2733633
[TBL] [Abstract][Full Text] [Related]
7. Comparison of a single-antigen microimmunofluorescence assay and inclusion fluorescent-antibody assay for detecting chlamydial antibodies and correlation of the results with neutralizing ability.
Peterson EM; Oda R; Tse P; Gastaldi C; Stone SC; de la Maza LM
J Clin Microbiol; 1989 Feb; 27(2):350-2. PubMed ID: 2644298
[TBL] [Abstract][Full Text] [Related]
8. Analysis of rectal Chlamydia trachomatis serovar distribution including L2 (lymphogranuloma venereum) at the Erasmus MC STI clinic, Rotterdam.
Waalboer R; van der Snoek EM; van der Meijden WI; Mulder PG; Ossewaarde JM
Sex Transm Infect; 2006 Jun; 82(3):207-11. PubMed ID: 16731669
[TBL] [Abstract][Full Text] [Related]
9. Effects of antibody isotype and host cell type on in vitro neutralization of Chlamydia trachomatis.
Peterson EM; Cheng X; Pal S; de la Maza LM
Infect Immun; 1993 Feb; 61(2):498-503. PubMed ID: 8423079
[TBL] [Abstract][Full Text] [Related]
10. Chlamydia trachomatis glycosaminoglycan-dependent and independent attachment to eukaryotic cells.
Chen JC; Stephens RS
Microb Pathog; 1997 Jan; 22(1):23-30. PubMed ID: 9032759
[TBL] [Abstract][Full Text] [Related]
11. Hemorrhagic proctitis due to lymphogranuloma venereum serogroup L2. Diagnosis by fluorescent monoclonal antibody.
Klotz SA; Drutz DJ; Tam MR; Reed KH
N Engl J Med; 1983 Jun; 308(26):1563-5. PubMed ID: 6602293
[TBL] [Abstract][Full Text] [Related]
12. Lymphogranuloma venereum serovar L2b in Portugal.
Castro R; Baptista T; Vale A; Nunes H; Prieto E; Araújo C; Mansinho K; da Luz Martins Pereira F
Int J STD AIDS; 2010 Apr; 21(4):265-6. PubMed ID: 20378898
[TBL] [Abstract][Full Text] [Related]
13. Deep comparative genomics among Chlamydia trachomatis lymphogranuloma venereum isolates highlights genes potentially involved in pathoadaptation.
Borges V; Gomes JP
Infect Genet Evol; 2015 Jun; 32():74-88. PubMed ID: 25745888
[TBL] [Abstract][Full Text] [Related]
14. Chlamydia trachomatis Mip-like protein.
Lundemose AG; Rouch DA; Birkelund S; Christiansen G; Pearce JH
Mol Microbiol; 1992 Sep; 6(17):2539-48. PubMed ID: 1406289
[TBL] [Abstract][Full Text] [Related]
15. Detection of Lymphogranuloma Venereum-Associated Chlamydia trachomatis L2 Serovars in Remnant Rectal Specimens Collected from 7 US Public Health Laboratories.
Chi KH; de Voux A; Morris M; Katz SS; Pillay A; Danavall D; Bowden KE; Gaynor AM; Kersh EN
Sex Transm Dis; 2022 Jan; 49(1):e26-e28. PubMed ID: 34075001
[TBL] [Abstract][Full Text] [Related]
16. Chlamydia trachomatis 60 kDa cysteine rich outer membrane protein: sequence homology between trachoma and LGV biovars.
Watson MW; Lambden PR; Ward ME; Clarke IN
FEMS Microbiol Lett; 1989 Dec; 53(3):293-7. PubMed ID: 2612891
[TBL] [Abstract][Full Text] [Related]
17. Serotyping of Chlamydia: antibodies to lymphogranuloma venereum strains compared by microimmunofluorescence and neutralization tests.
Banks J; Schachter J
Infect Immun; 1978 Jun; 20(3):864-6. PubMed ID: 352964
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the humoral response elicited in mice by a chimeric peptide representing variable segments I and IV of the major outer membrane protein of Chlamydia trachomatis.
Qu Z; Cheng X; de la Maza LM; Peterson EM
Vaccine; 1994 May; 12(6):557-64. PubMed ID: 7518628
[TBL] [Abstract][Full Text] [Related]
19. Chlamydia trachomatis species-specific epitope detected on mouse biovar outer membrane protein.
Stephens RS; Kuo CC
Infect Immun; 1984 Sep; 45(3):790-1. PubMed ID: 6205997
[TBL] [Abstract][Full Text] [Related]
20. Immunotyping of Chlamydia trachomatis with monoclonal antibodies.
Wang SP; Kuo CC; Barnes RC; Stephens RS; Grayston JT
J Infect Dis; 1985 Oct; 152(4):791-800. PubMed ID: 4045232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]